GSK2194069
GSK2194069 is an active β-keto reductase (KR) -specific inhibitor of fatty acid synthase (FASN) with an IC50 of 7.7 nM in an assay for the detection of released CoA.GSK2194069 inhibits the proliferation of FAS in cancer cells through the action of acetoacetyl-coenzyme A and NADPH.
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
428.48
Molecular Formula
C25H24N4O3
Notes
Research use only, not for human use.
Receptor
NADPH | Fatty Acid Synthase
CAS Number
1332331-08-4
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1438764-01 0.02 mg (E-Coli)
Recombinant Human Alanine--glyoxylate aminotransferase 2-like 1 (AGXT2L1)
Ask
View Details MBS1438764-02 0.02 mg (Yeast)
Recombinant Human Alanine--glyoxylate aminotransferase 2-like 1 (AGXT2L1)
Ask
View Details